Ching-Yuan is a fifth-year PhD student who joined the Pharmaceutical Outcomes and Policy program at UF in Fall 2018, working under the direction of Dr. Lo-ciganic. Ching-Yuan received her bachelor’s degree in Pharmacy and Master’s in pharmacoepidemiology in Taiwan.
Her disease area of interest is oncology, including breast cancer and melanoma. Her current research includes evaluating long term safety and effectiveness outcomes among breast cancer survivors.